The Oncology Brothers are joined by nationally renowned researcher and thoracic oncologist Charu Aggarwal, MD, MPH, of Penn Center for Precision Medicine, to discuss a treatment algorithm for localized non-small cell lung cancer (NSCLC). The trio detail the best treatment approaches for stage I-III NSCLC – stages where therapy is administered with curative intent.
A Top-Notch Treatment Algorithm for Localized Non-Small Cell Lung Cancer
By Oncology Brothers - Last Updated: March 15, 2023Related Posts
The efficacy of zongertinib was evaluated in Beamion LUNG-1, an open-label, multicenter, multi-cohort trial.
FLAURA2 Principal Investigator, Pasi A. Jänne, MD, PhD, discusses the final overall survival analysis from the phase 3 ...
Osimertinib plus chemotherapy showed a “statistically significant and clinically meaningful improvement" in overall ...
In the second segment of this interview, Feldman discussed the importance of patient advocacy in clinical trial research.
Jorge Nieva, MD, explains new findings showing how steroids impact survival in patients undergoing ICI therapy.
Latest News
Physician's Weekly
630 Madison Ave.
Manalapan, NJ 07726
Connect
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.